Institutional Ownership Eye Point Pharmaceuticals, Inc. (EYPT)
This table provides information about the institutional ownership of Eye Point Pharmaceuticals, Inc. (EYPT). We have compiled data on the 167 institutions that hold shares in the stock, with a total of 68 Million shares, which have been reported (via 13F filing form) to have a value of $805 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Cormorant Asset Management, LP
Boston, MA |
Nov 14, 2025 Q3 2025 |
8,325,000
shares
|
$98.7 Million
18.35% of portfolio
|
Q2 2024
Added 20.77%
|
|
|
Suvretta Capital Management, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
6,192,715
shares
|
$73.4 Million
2.57% of portfolio
|
Q3 2025
Reduced 8.99%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2025 Q3 2025 |
5,559,782
shares
|
$65.9 Million
0.13% of portfolio
|
Q3 2025
Reduced 18.24%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 03, 2025 Q3 2025 |
4,416,332
shares
|
$52.3 Million
0.12% of portfolio
|
Q3 2025
Reduced 3.98%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 13, 2025 Q3 2025 |
4,171,884
shares
|
$49.4 Million
0.02% of portfolio
|
Q3 2025
Reduced 3.0%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
3,794,516
shares
|
$45 Million
0.0% of portfolio
|
Q3 2025
Reduced 0.21%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,764,881
shares
|
$44.6 Million
0.0% of portfolio
|
Q2 2024
Added 35.07%
|
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Nov 14, 2025 Q3 2025 |
3,572,335
shares
|
$42.3 Million
5.54% of portfolio
|
Q4 2024
Added 287.31%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
2,135,389
shares
|
$25.3 Million
0.0% of portfolio
|
Q3 2025
Reduced 8.91%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
2,005,365
shares
|
$23.8 Million
0.89% of portfolio
|
Q3 2025
New holding
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
1,796,000
shares
|
$21.3 Million
0.85% of portfolio
|
Q3 2025
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
1,524,526
shares
|
$18.1 Million
0.0% of portfolio
|
Q3 2025
Reduced 4.24%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
1,514,606
shares
|
$17.9 Million
0.0% of portfolio
|
Q3 2025
Added 18.26%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
1,473,199
shares
|
$17.5 Million
0.0% of portfolio
|
Q3 2025
Reduced 2.79%
|
|
|
Essex Woodlands Management, Inc.
The Woodlands, TX |
Nov 12, 2025 Q3 2025 |
1,084,857
shares
|
$12.9 Million
4.9% of portfolio
|
Q3 2025
Reduced 7.27%
|
|
|
5 Am Venture Management, LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
1,050,000
shares
|
$12.4 Million
9.75% of portfolio
|
Q3 2024
Added 2000.0%
|
|
|
Patient Square Capital LP
Menlo Park, CA |
Nov 10, 2025 Q3 2025 |
1,011,839
shares
|
$12 Million
3.85% of portfolio
|
Q3 2025
Reduced 25.21%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
1,010,331
shares
|
$12 Million
0.0% of portfolio
|
Q3 2025
Added 24.1%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
978,129
shares
|
$11.6 Million
0.0% of portfolio
|
Q3 2025
Added 24.98%
|
|
|
Abrdn PLC
|
Nov 06, 2025 Q3 2025 |
796,802
shares
|
$9.44 Million
0.02% of portfolio
|
Q3 2025
Reduced 22.73%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
756,087
shares
|
$8.96 Million
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Hsbc Holdings PLC
London, X0 |
Nov 13, 2025 Q3 2025 |
716,453
shares
|
$8.49 Million
0.01% of portfolio
|
Q3 2025
Added 13.53%
|
|
|
Artia Global Partners LP
Miami, FL |
Nov 14, 2025 Q3 2025 |
628,367
shares
|
$7.45 Million
1.42% of portfolio
|
Q3 2025
Added 98.41%
|
|
|
Principia Wealth Advisory, LLC
Dallas, TX |
Aug 14, 2025 Q2 2025 |
533,778
shares
|
$6.33 Million
4.25% of portfolio
|
Q1 2025
Added 97.42%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
531,723
shares
|
$6.3 Million
0.0% of portfolio
|
Q3 2025
Added 180.03%
|
|